Metformin, sold under the brand name Glucophage, among others, is the main first-line medication for the treatment of type 2 diabetes, particularly in... 142 KB (13,772 words) - 06:08, 27 April 2024 |
Sitagliptin/metformin, sold under the brand name Janumet among others, is a fixed-dose combination anti-diabetic medication used to treat type 2 diabetes... 11 KB (745 words) - 06:24, 24 March 2024 |
Dapagliflozin (redirect from Dapagliflozin/metformin hydrochloride) type 2 diabetes as an adjunct to diet and exercise: as monotherapy when metformin is considered inappropriate due to intolerance; in addition to other medicinal... 52 KB (4,829 words) - 04:26, 20 April 2024 |
Dapagliflozin/metformin, sold under the brand name Xigduo XR amongst others, is a fixed-dose combination anti-diabetic medication used as an adjunct to... 8 KB (370 words) - 07:16, 24 March 2024 |
Empagliflozin/metformin, sold under the brand name Synjardy among others, is a fixed-dose combination anti-diabetic medication used to treat type 2 diabetes... 9 KB (558 words) - 19:21, 17 March 2024 |
Pioglitazone/metformin, sold under the brand name Actoplus Met among others, is a fixed-dose combination anti-diabetic medication used to improve glycemic... 7 KB (536 words) - 05:58, 18 March 2024 |
Glibenclamide/metformin, also known as glyburide/metformin and sold under the brand name Glucovance, is a fixed-dose combination anti-diabetic medication... 4 KB (144 words) - 07:01, 2 December 2023 |
Vildagliptin/metformin, sold under the brand name Eucreas among others, is a fixed-dose combination anti-diabetic medication for the treatment of type... 6 KB (402 words) - 20:08, 20 December 2023 |
Vildagliptin (section Combination with metformin) Agency has also approved a combination of vildagliptin and metformin, vildagliptin/metformin (Eucreas by Novartis) as an oral treatment for type-2 diabetes... 8 KB (691 words) - 00:40, 4 March 2024 |
Alogliptin (redirect from Alogliptin/metformin) commonly used in combination with metformin in people whose diabetes cannot adequately be controlled with metformin alone. In April 2016, the U.S. Food... 12 KB (894 words) - 22:13, 31 March 2024 |
approved in 2019, consisting of metformin, saxagliptin, and dapagliflozin. Another triple combination approval for metformin, linagliptin, and empagliflozin... 49 KB (5,098 words) - 10:55, 4 April 2024 |
Ertugliflozin (redirect from Ertugliflozin/metformin) monotherapy and as a fixed dose combination with either sitagliptin or with metformin. In the European Union, it was approved in March 2018, for use as a monotherapy... 13 KB (913 words) - 23:08, 17 April 2024 |
limited evidence if the combined used of Metformin with Sulphonylurea compared to the combination of Metformin plus another glucose-lowering intervention... 23 KB (2,571 words) - 14:42, 13 April 2024 |
Canagliflozin/metformin, sold under the brand name Vokanamet among others, is a fixed-dose combination anti-diabetic medication used for the treatment... 6 KB (398 words) - 03:02, 19 April 2024 |
line pharmacological therapy for type 2 diabetes (usually together with metformin), specifically in patients with chronic kidney disease, cardiovascular... 44 KB (4,550 words) - 18:20, 14 April 2024 |
2021 found that semaglutide, when used once weekly as add-on therapy to metformin in people with type 2 diabetes, was found to be inferior to tirzepatide... 66 KB (5,383 words) - 10:23, 22 April 2024 |
Empagliflozin/linagliptin/metformin, sold under the brand name Trijardy XR, is a drug combination used for the treatment of type 2 diabetes. It is a combination... 8 KB (345 words) - 19:31, 20 December 2023 |
Galega officinalis (section Relation to metformin) blood glucose-lowering activity and the foundation for the discovery of metformin, Italian fitch, a treatment for managing symptoms of diabetes mellitus... 8 KB (829 words) - 19:44, 13 January 2024 |
infarction, non-fatal stroke or end-stage renal disease when comparing metformin monotherapy to dipeptidyl peptidase-4 inhibitors for the treatment of... 16 KB (1,798 words) - 07:40, 1 February 2024 |
combinations empagliflozin/linagliptin, empagliflozin/metformin, and empagliflozin/linagliptin/metformin. For cardiovascular death, the FDA based its decision... 30 KB (2,501 words) - 06:21, 7 April 2024 |
in combination with other medicines for type 2 diabetes, in particular metformin, sulfonylureas, thiazolidinediones, and insulin taken concomitantly with... 16 KB (1,512 words) - 06:23, 7 April 2024 |
a second-line therapy for diabetes following first-line therapy with metformin. Its effects on long-term health outcomes like heart disease and life... 31 KB (2,653 words) - 01:05, 23 February 2024 |
Metformin and alogliptin A10BD14 Metformin and repaglinide A10BD15 Metformin and dapagliflozin A10BD16 Metformin and canagliflozin A10BD17 Metformin and... 6 KB (508 words) - 06:49, 20 December 2023 |